Diversity in mechanisms of substrate oxidation by cytochrome P450 2D6 - Lack of an allosteric role of nadph-cytochrome P450 reductase in catalytic regioselectivity

被引:43
作者
Hanna, IH
Krauser, JA
Cai, HL
Kim, MS
Guengerich, FP
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA
关键词
D O I
10.1074/jbc.M106841200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 (P450) 2D6 was first identified as the polymorphic human debrisoquine hydroxylase and subsequently shown to catalyze the oxidation of a variety of drugs containing a basic nitrogen. Differences in the regioselectivity of oxidation products formed in systems containing NADPH-P450 reductase/NADPH and the model oxidant cumene hydroperoxide have been proposed by others to be due to an allosteric influence of the reductase on P450 2D6 (Modi, S., Gilham, D. E., Sutcliffe, M. J., Lian, L.-Y., Primrose, W. U., Wolf, C. R., and Roberts, G. C. K. (1997) Biochemistry 36, 4461-4470). We examined the differences in the formation of oxidation products of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, metoprolol, and bufuralol between reductase-, cumene hydroperoxide-, and iodosylbenzene-supported systems. Catalytic regioselectivity was not influenced by the presence of the reductase in any of the systems supported by model oxidants, ruling out allosteric influences. The presence of the reductase had little effect on the affinity of P450 2D6 for any of these three substrates. The addition of the reaction remnants of the model oxidants (cumyl alcohol and iodobenzene) to the reductase-supported system did not affect reaction patterns, arguing against steric influences of these products on catalytic regioselectivity. Label from (H2O)-O-18 was quantitatively incorporated into 1'-hydroxybufuralol in the iodosylbenzene- but not in the reductase- or cumene hydroperoxide-supported reactions. We conclude that the P450 systems utilizing NADPH-P450 reductase, cumene hydroperoxide, and iodosylbenzene use similar but distinct chemical mechanisms. These differences are the basis for the variable product distributions, not an allosteric influence of the reductase.
引用
收藏
页码:39553 / 39561
页数:9
相关论文
共 86 条
[1]   Allosteric behavior in cytochrome P450-dependent in vitro drug-drug interactions: A prospective based on conformational dynamics [J].
Atkins, WM ;
Wang, RW ;
Lu, AYH .
CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (04) :338-347
[2]   Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer [J].
Auchus, RJ ;
Lee, TC ;
Miller, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) :3158-3165
[3]   Reaction of cytochrome P450 with cumene hydroperoxide: ESR spin trapping evidence for the homolytic scission of the peroxide O-O bond by ferric cytochrome P450 1A2 [J].
Barr, DP ;
Martin, MV ;
Guengerich, FP ;
Mason, RP .
CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (01) :318-325
[4]  
BLAKE RC, 1981, J BIOL CHEM, V256, P2127
[5]  
BLAKE RC, 1981, J BIOL CHEM, V256, P5755
[6]   ENZYMATIC MONOOXYGENATION OF HALOGEN ATOMS - CYTOCHROME-P-450 CATALYZED OXIDATION OF IODOBENZENE BY IODOSOBENZENE [J].
BURKA, LT ;
THORSEN, A ;
GUENGERICH, FP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1980, 102 (25) :7615-7616
[7]   DIFFERENCES IN THE MECHANISM OF NADPH-SUPPORTED AND CUMENE HYDROPEROXIDE-SUPPORTED REACTIONS OF CYTOCHROME-P-450 [J].
CAPDEVILA, J ;
ESTABROOK, RW ;
PROUGH, RA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1980, 200 (01) :186-195
[8]   COMPARISON OF SUBSTRATE METABOLISM BY WILD-TYPE CYP2D6 PROTEIN AND A VARIANT CONTAINING METHIONINE, NOT VALINE, AT POSITION-374 [J].
CRESPI, CL ;
STEIMEL, DT ;
PENMAN, BW ;
KORZEKWA, KR ;
FERNANDEZSALGUERO, P ;
BUTERS, JTM ;
GELBOIN, HV ;
GONZALEZ, FJ ;
IDLE, JR ;
DALY, AK .
PHARMACOGENETICS, 1995, 5 (04) :234-243
[9]   Nomenclature for human CYP2D6 alleles [J].
Daly, AK ;
Brockmoller, J ;
Broly, F ;
Eichelbaum, M ;
Evans, WE ;
Gonzalez, FJ ;
Huang, JD ;
Idle, JR ;
IngelmanSundberg, M ;
Ishizaki, T ;
JacqzAigrain, E ;
Meyer, UA ;
Nebert, DW ;
Steen, VM ;
Wolf, CR ;
Zanger, UM .
PHARMACOGENETICS, 1996, 6 (03) :193-201
[10]   THE GENETIC-CONTROL OF BUFURALOL METABOLISM IN MAN [J].
DAYER, P ;
BALANT, L ;
COURVOISIER, F ;
KUPFER, A ;
KUBLI, A ;
GORGIA, A ;
FABRE, J .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1982, 7 (01) :73-77